Showing results (661-670 of 697) with videos related to

Sort By:
Pageof 70
Leukemia & Lymphoma|July 9, 2025
Ibrutinib added to standard conditioning and as maintenance therapy following autologous hematopoietic stem cell transplantation for relapsed or refractory activated-B-cell type Diffuse Large B-cell lymphoma: primary analysis of the US intergroup double-blind randomized phase III study Alliance A051301/BMT-CTN 1201Charalambos Andreadis, Olivia Bobek, Eric D Hsi, et al.
Molecular Psychiatry|May 16, 2012
Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk predictionM Ayalew, H Le-Niculescu, D F Levey, et al.
Leukemia Research|July 31, 2007
Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemiaRebekah L Browning, Susan M Geyer, Amy J Johnson, et al.
Function (Oxford, England)|September 28, 2022
Noncanonical Role of Telomerase in Regulation of Microvascular Redox Environment With Implications for Coronary Artery DiseaseK Ait-Aissa, L E Norwood-Toro, J Terwoord, et al.
Hypertension (Dallas, Tex. : 1979)|November 27, 2024
UBR1 Promotes Sex-Dependent ACE2 Ubiquitination in HypertensionMona Elgazzaz, Navya Lakkappa, Clara Berdasco, et al.
Journal of Medicinal Chemistry|January 2, 2010
Application of fragment-based NMR screening, X-ray crystallography, structure-based design, and focused chemical library design to identify novel microM leads for the development of nM BACE-1 (beta-site APP cleaving enzyme 1) inhibitorsYu-Sen Wang, Corey Strickland, Johannes H Voigt, et al.
Cancer|April 15, 2025
Contemporary neighborhood redlining and racial mortgage lending bias and disparities in prostate cancer survivalWayne R Lawrence, Neal D Freedman, Jennifer K McGee-Avila, et al.
Medrxiv : the Preprint Server for Health Sciences|June 3, 2024
UBR1 Promotes Sex-Dependent ACE2 Ubiquitination in HypertensionMona Elgazzaz, Navya Lakkappa, Clara Berdasco, et al.
Blood|November 15, 2008
Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximabFarrukh T Awan, Neil E Kay, Melanie E Davis, et al.
Leukemia & Lymphoma|November 30, 2012
A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulinJeremy T Larsen, William J Hogan, Ivana N Micallef, et al.
Pageof 70